shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

Destiny Media Is Like A Late-Stage Biotech Company, But One With Limited Downside

April 17th, 2017 · No Comments

  • Destiny Media has a stable core in the form of a profitable product that is growing again, limiting the downside to the stock price.
  • They have another product in development which addresses a much bigger market, but this is not yet good enough and needs further work.
  • Given the limited downside and considerable upside, what is important is reaching proof of concept, showing that the product is good enough to sell.
  • We are getting more optimistic that the company will be able to pull that off, as they’ve done this already for one segment.
  • Therefore, the way to see this company is as a fairly late stage biotech company with limited downside.

Destiny Media Is Like A Late-Stage Biotech Company, But One With Limited Downside

Tags: DSNY